Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Jul 2009;3(4):635-643
Phase 2 results expected in 1H 2026 DNL921ATV:Abeta / Amyloid beta / Antibody TransportVehicle therapeutic / Neurodegenerative diseaseAlzheimer's diseaseIND-enablingPhase 1/1b initiation planned DNL111ETV:GCase / GCase / Enzyme TransportVehicle biologic / Neurodegenerative disease
Although it may take several years for HS-10535 to reach commercialization, Merck is clearly optimistic about its oral delivery convenience and its potential benefits in weight loss and cardiovascular metabolism
Consulting a healthcare professional before starting any supplement is advised
US$ 22.21
US$ 27.47
US$ 25.60
US$ 24.60
US$ 21.17
US$ 25.33
US$ 23.19
